π Osimert 80 mg Tablets
(Osimertinib) β Targeted Therapy That Makes a Difference
Your Smart Choice in the Fight Against EGFR Mutation-Positive Lung Cancer
β
Product Highlights:
πΉ Brand Name: Osimert
πΉ Generic Name: Osimertinib (as mesylate)
πΉ Strength: 80 mg
πΉ Pack Size: 30 Tablets per bottle
πΉ Manufacturer: Everest Pharmaceuticals Ltd.
πΉ Marketed by: NP Molecule β Oncology You Can Trust
𧬠Why Choose Osimert?
Osimert 80 mg is a next-generation EGFR-TKI (Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor) specially designed to overcome resistance in EGFR T790M mutation-positive non-small cell lung cancer (NSCLC).
π₯ Powerful & Precise: Targets both sensitizing EGFR mutations and the resistant T790M mutation.
π Clinically Proven: Extends progression-free and overall survival.
π― First-Line & Beyond: Approved for use in both first-line therapy and after EGFR-TKI resistance.
π How It Works:
Osimertinib binds irreversibly to mutant EGFR receptors, blocking tumor cell growth and preventing disease progressionβwhile sparing normal cells for fewer side effects.
π¨ββοΈ Indications:
βοΈ First-line treatment of metastatic EGFR mutation-positive NSCLC
βοΈ Treatment of EGFR T790M mutation-positive NSCLC after prior EGFR-TKI therapy
π Dosage & Administration:
π Take 1 tablet (80 mg) orally once daily
π½οΈ Can be taken with or without food
β³ Continue until disease progression or unacceptable toxicity
β οΈ Possible Side Effects:
-
Mild: Diarrhea, skin rash, fatigue
-
Rare but serious: Interstitial lung disease, heart rhythm issues (QT prolongation)
π Regular monitoring is recommended
π§ Storage Instructions:
π’ Marketed By β NP Molecule
π Sector-14, Uttara, Dhaka β 1230, Bangladesh
π +8801844288466
π§ npmolecule23@gmail.com
π www.npmoleculeoncology.com
π± Scan the QR code for more info or ordering assistance
π‘οΈ Elevate Cancer Care. Choose Osimert.
Trusted. Targeted. Transformational.